Brett Staahl

Brett Staahl

Company: Scribe Therapeutics

Job title: Vice President Platform, Co- Founder


Solving the Challenges of Editing & In Vivo Delivery 10:50 am

• Engineering of natural CRISPR systems can hone therapeutic characteristics • CasX based systems allow for efficient use of AAV • Holistic re-engineering of natural enzymes paves a way to treat diseases with significant unmet needRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.